Clinical Trials of Immune Checkpoint Inhibitors as First Line Therapy for Advanced NSCLC

GRACE Videos and Articles

LCAM 2015


Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a first line treatment for patients with advanced NSCLC and highlights details of two trials testing this question.

November is Lung Cancer Awareness Month. What are you grateful for?

Watch, read, and then share your own stories of empowerment in our online forum. Your story may inspire others.


Get more information about the IMpower-110 Trial and CheckMate-227 Trial.

[ratingwidget post_id=0]

Check out more LCAM videos & posts here.


Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation